Lupus, vaccinations and COVID-19: What we know nowAlice Mason, Christopher J Edwards, Christopher Holroyd et al.|Lupus|2021Cited by 29
CAR T Cell Therapy: A New Hope for Refractory Lupus?Michael Alsharkawy, Christopher J Edwards, Alice Mason et al.|touchREVIEWS in RMD|2023Cited by 2
Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?May Lwin, Christopher J Edwards, Christopher Holroyd et al.|Rheumatology Advances in Practice|2020Cited by 1